Protective mechanisms of simvastatin in experimental periodontal disease

Journal of Periodontology

Volumn 84, Issue 8, 2013, Pages 1145-1157

  Dalcico, Roberta ^a   De Menezes, Adriana M A ^a   Deocleciano, Otacilio B ^a   Oriá, Reinaldo B ^a   Vale, Mariana L ^a   Ribeiro, Ronaldo A ^a   De C Brito, Gerly A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Alveolar bone loss; Hydroxymethylglutaryl CoA reductase inhibitors; Inflammation; Periodontitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN 2; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MALONALDEHYDE; MATRIX METALLOPROTEINASE 1, RAT; MATRIX METALLOPROTEINASE-1, RAT; NEUTROPHIL COLLAGENASE; NITRATE; NITRITE; NOS2 PROTEIN, RAT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PEROXIDASE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SIMVASTATIN; TNFRSF11B PROTEIN, RAT; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GINGIVA; OXIDATIVE STRESS; PERIODONTITIS; RAT; WISTAR RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ALVEOLAR BONE LOSS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; BONE MORPHOGENETIC PROTEIN 2; FEMALE; GINGIVA; GLUTATHIONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 8; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OSTEOPROTEGERIN; OXIDATIVE STRESS; PERIODONTITIS; PEROXIDASE; RANK LIGAND; RATS; RATS, WISTAR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIMVASTATIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84882288944     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120114     Document Type: Article

References (50)

1. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated metaanalysis. Clin Ther 2009;31:236-244.
2. Zhang FL, Casey PJ. Protein prenylation: Molecular mechanisms and functional consequences. Annu Rev Biochem 1996;65:241-269.
3. Buhaescu I, Izzedine H. Mevalonate pathway: A review of clinical and therapeutical implications. Clin Biochem 2007;40:575-584.
4. Zeiser R, Maas K, Youssef S, Dürr C, Steinman L, Negrin RS. Regulation of different inflammatory diseases by impacting the mevalonate pathway. Immunology 2009;127:18-25.
5. Horiuchi N, Maeda T. Statins and bone metabolism. Oral Dis 2006;12:85-101.
6. Gotoh M, Mizuno K, Ono Y, Takahashi M. Fluvastatin increases bone mineral density in postmenopausal women. Fukushima J Med Sci 2011;57:19-27.
7. Yue J, Zhang X, Dong B, Yang M. Statins and bone health in postmenopausal women: A systematic review of randomized controlled trials. Menopause 2010;17:1071-1079.
8. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
9. Vaziri H, Naserhojjati-Roodsari R, Tahsili-Fahadan N, et al. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats. J Periodontol 2007;78:1561-1567.
10. Seto H, Ohba H, Tokunaga K, Hama H, Horibe M, Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res 2008;43:261-267.
11. Pradeep AR, Thorat MS. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: A randomized clinical trial. J Periodontol 2010;81:214-222.
12. Cunha-Cruz J, Saver B, Maupome G, Hujoel PP. Statin use and tooth loss in chronic periodontitis patients. J Periodontol 2006;77:1061-1066.
13. Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health 2008;8:16.
14. Bezerra MM, de Lima V, Alencar VB, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009-1014.
15. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-1949.
16. Ho ML, Chen YH, Liao HJ, et al. Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats. Eur J Clin Invest 2009;39:296-303.
17. Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T. Observations on experimental marginal periodontitis in rats. J Periodontal Res 2004;39:101-106.
18. Leitão RF, Ribeiro RA, Chaves HV, Rocha FA, Lima V, Brito GA. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J Periodontol 2005;76:956-963.
19. Lima-Júnior RC, Figueiredo AA, Freitas HC, et al. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: Role of cytokines on inducible nitric oxide synthase activation. Cancer Chemother Pharmacol 2012;69:931-942.
20. Sedlak J, Lindsay RH. Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205.
21. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-278.
22. de Menezes AM, de Souza GF, Gomes AS, et al. S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats. J Periodontol 2012;83:514-521.
23. Hsu SM, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981; 29:1349-1353.
24. Meulman T, Peruzzo DC, Stipp RN, et al. Impact of Porphyromonas gingivalis inoculation on ligatureinduced alveolar bone loss. A pilot study in rats. J Periodontal Res 2011;46:629-636.
25. Sangwan A, Tewari S, Singh H, Sharma RK, Narula SC. Periodontal status and hyperlipidemia: Statin users versus non-users. J Periodontol 2013;84:3-12.
26. Nassar PO, Nassar CA, Guimarães MR, et al. Simvastatin therapy in cyclosporine A-induced alveolar bone loss in rats. J Periodontal Res 2009;44: 479-488.
27. Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 2003;144:681-692.
28. Hughes A, Rogers MJ, Idris AI, Crockett JC. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Calcif Tissue Int 2007;81:403-413.
29. Sibai T, Morgan EF, Einhorn TA. Anabolic agents and bone quality. Clin Orthop Relat Res 2011;469: 2215-2224.
30. Koh KK, Son JW, Ahn JY, et al. Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2002;22:e19-e23.
31. Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res 2006;85:520-523.
32. Zhang X, Markovic-Plese S. Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response. Immunol Res 2008;41:165-174.
33. Nachtigal P, Kopecky M, Solichova D, Zdansky P, Semecky V. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis. J Pharm Pharmacol 2005;57:197-203.
34. Abeles AM, Pillinger MH. Statins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy? Arthritis Rheum 2006;54: 393-407.
35. Stenvinkel P, Rodríguez-Ayala E, Massy ZA, et al. Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2006;1:281-287.
36. Nezić L, Skrbić R, Dobrić S, et al. Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Basic Clin Pharmacol Toxicol 2009;104:185-191.
37. Yin H, Shi ZG, Yu YS, et al. Protection against osteoporosis by statins is linked to a reduction of oxidative stress and restoration of nitric oxide formation in aged and ovariectomized rats. Eur J Pharmacol 2012; 674:200-206.
38. Ahmad T, Mabalirajan U, Sharma A, et al. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: From asymmetric dimethyl-arginine to asthma. Am J Respir Cell Mol Biol 2011;44:531-539.
39. Trocha M, Merwid-Lad A, Szuba A, et al. Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver. Pharmacol Rep 2010;62:343-351.
40. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation 2001;103:926-933.
41. Barter MJ, Hui W, Lakey RL, Catterall JB, Cawston TE, Young DA. Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation. Ann Rheum Dis 2010;69:2189-2198.
42. Kaji H, Kanatani M, Sugimoto T, Chihara K. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bonecell cultures. Horm Metab Res 2005;37:589-592.
43. Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB. Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factorkappaB ligand through modulation of NF-kappaB pathway. Int J Cancer 2008;123:1733-1740.
44. Ayukawa Y, Yasukawa E, Moriyama Y, et al. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107: 336-342.
45. Endo A, Tsujita Y, Kuroda M, Tanzawa K. Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta 1979;575:266-276.
46. Dale KM, White CM, Henyan NN, Kluger J, Coleman CI. Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med 2007;120:706-712.
47. Abel T, Fehé r J, Dinya E, Eldin MG, Kovács A. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease. Med Sci Monit 2009;15:MS6-MS11.
48. Galus R, Wiodarski P, Wiodarski K. Influence of fluvastatin on bone formation induced by demineralized bone matrix in mice. Pharmacol Rep 2006;58: 443-447.
49. Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 2007;18:1641-1650.
50. Tikiz C, Unlü Z, Tikiz H, et al. The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: Negative correlation between TNF-alpha and anabolic bone parameters. J Bone Miner Metab 2004;22:365-371.